Guang-Yu Liu (Guangyu Liu)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Topics

Peritoneal Dialysis

Transforming Growth Factor

Ejection Fraction

Top Venues

British journal of cancer

The British journal of surgery

Journal of the National Cancer Institute

International journal of surgery (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2023)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2023)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2023)
Jian-Wei Li, Jian-Wei Li, Ying Zhang, Huai-Liang Wu, Miao Mo, Na Hu, Zhi-Ming Shao, Guang-Yu Liu
Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: a prospective clinical study. The British journal of surgery (2023)
Ying Zhang, Junjie Li, Miao Mo, Juping Shen, Hui Ren, Shiping Li, Guang-Yu Liu, Zhimin Shao
The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial. International journal of surgery (London, England) (2023)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer 128 (4) (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer 128 (4) (2022)
Ding Ma, Si-Yu Chen, Jin-Xiao Ren, Yu-Chen Pei, Cong-Wei Jiang, Shen Zhao, Yi Xiao, Xiao-En Xu, Guang-Yu Liu, Xin Hu, Xiao-Zhen Liang, Ke-Da Yu, Da-Qiang Li, Yi-Zhou Jiang, Zhi-Ming Shao
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer. Journal of the National Cancer Institute 113 (7) (2022)
Ying-Ying Liu, Hong-Yi Liu, Tian-Jian Yu, Qin Lu, Fang-Lin Zhang, Guang-Yu Liu, Zhi-Ming Shao, Da-Qiang Li
O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression. Cell death and differentiation 29 (4) (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer 128 (4) (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer 128 (4) (2022)
Si-Yu Wu, Jian-Wei Li, Huai-Liang Wu, Zhi-Ming Shao, Guang-Yu Liu, Na Hu
Accuracy of ultrasound-guided targeted fine-needle aspiration in assessing nodal response in node-positive breast cancer after neoadjuvant chemotherapy: prospective feasibility study. The British journal of surgery 109 (12) (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer 128 (4) (2022)
Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He, Yue Gong, Miao Mo, Wai-Kit Ming, Guang-Yu Liu
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British journal of cancer (2022)
Jian-Wei Li, Wen-Jia Zuo, Diana Ivanova, Xiao-Qing Jia, Li Lei, Guang-Yu Liu
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial. Breast cancer research and treatment 173 (2) (2018)